8,883 research outputs found
Table_S5._Detailed_information_for_gene_markers – Supplemental material for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX
No full textSupplemental material, Table_S5._Detailed_information_for_gene_markers for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX by Jing Li, Jingtao Li, Na Lyu, Yue Ma, Fei Liu, Yuqing Feng, Li Yao, Zhiyong Hou, Xiaofeng Song, Hongchuan Zhao, Xiaoya Li, Yingdian Wang, Cheng Xiao and Baoli Zhu in Therapeutic Advances in Chronic Disease</p
Supplementary_Figure_S1.Bray-Curitis_distance_between_all_samples.svg – Supplemental material for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX
No full textSupplemental material, Supplementary_Figure_S1.Bray-Curitis_distance_between_all_samples.svg for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX by Jing Li, Jingtao Li, Na Lyu, Yue Ma, Fei Liu, Yuqing Feng, Li Yao, Zhiyong Hou, Xiaofeng Song, Hongchuan Zhao, Xiaoya Li, Yingdian Wang, Cheng Xiao and Baoli Zhu in Therapeutic Advances in Chronic Disease</p
Table_S3__Relative_abundance_profile_at_each_taxonomy_level – Supplemental material for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX
No full textSupplemental material, Table_S3__Relative_abundance_profile_at_each_taxonomy_level for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX by Jing Li, Jingtao Li, Na Lyu, Yue Ma, Fei Liu, Yuqing Feng, Li Yao, Zhiyong Hou, Xiaofeng Song, Hongchuan Zhao, Xiaoya Li, Yingdian Wang, Cheng Xiao and Baoli Zhu in Therapeutic Advances in Chronic Disease</p
An Interview with an Author and Editor: The View from Taiwan
No full textORCID Engagement Manager Asia-Pacific, Estelle Cheng, recently spoke with Wen-Yau Cathy Lin, an academic, author and scholarly journal editor about ORCID and its use in Taiwan
Table_S2_Data_information_of_HiSeq_sequencing – Supplemental material for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX
No full textSupplemental material, Table_S2_Data_information_of_HiSeq_sequencing for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX by Jing Li, Jingtao Li, Na Lyu, Yue Ma, Fei Liu, Yuqing Feng, Li Yao, Zhiyong Hou, Xiaofeng Song, Hongchuan Zhao, Xiaoya Li, Yingdian Wang, Cheng Xiao and Baoli Zhu in Therapeutic Advances in Chronic Disease</p
Supplementary_Figure_S3._Genus_construction_of_enterotype_changed_patients_during_FOLFOX_treatment – Supplemental material for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX
No full textSupplemental material, Supplementary_Figure_S3._Genus_construction_of_enterotype_changed_patients_during_FOLFOX_treatment for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX by Jing Li, Jingtao Li, Na Lyu, Yue Ma, Fei Liu, Yuqing Feng, Li Yao, Zhiyong Hou, Xiaofeng Song, Hongchuan Zhao, Xiaoya Li, Yingdian Wang, Cheng Xiao and Baoli Zhu in Therapeutic Advances in Chronic Disease</p
Table_S4__AUC_of_each_combination – Supplemental material for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX
No full textSupplemental material, Table_S4__AUC_of_each_combination for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX by Jing Li, Jingtao Li, Na Lyu, Yue Ma, Fei Liu, Yuqing Feng, Li Yao, Zhiyong Hou, Xiaofeng Song, Hongchuan Zhao, Xiaoya Li, Yingdian Wang, Cheng Xiao and Baoli Zhu in Therapeutic Advances in Chronic Disease</p
Supplementary_Figure_S2.Shift_of_gut_enterotypes_in_patients_with_FOLFOX_treatment – Supplemental material for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX
No full textSupplemental material, Supplementary_Figure_S2.Shift_of_gut_enterotypes_in_patients_with_FOLFOX_treatment for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX by Jing Li, Jingtao Li, Na Lyu, Yue Ma, Fei Liu, Yuqing Feng, Li Yao, Zhiyong Hou, Xiaofeng Song, Hongchuan Zhao, Xiaoya Li, Yingdian Wang, Cheng Xiao and Baoli Zhu in Therapeutic Advances in Chronic Disease</p
Authorship-Change-Request-Form-P2 – Supplemental material for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX
No full textSupplemental material, Authorship-Change-Request-Form-P2 for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX by Jing Li, Jingtao Li, Na Lyu, Yue Ma, Fei Liu, Yuqing Feng, Li Yao, Zhiyong Hou, Xiaofeng Song, Hongchuan Zhao, Xiaoya Li, Yingdian Wang, Cheng Xiao and Baoli Zhu in Therapeutic Advances in Chronic Disease</p
Authorship-Change-Request-Form-P3 – Supplemental material for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX
No full textSupplemental material, Authorship-Change-Request-Form-P3 for Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX by Jing Li, Jingtao Li, Na Lyu, Yue Ma, Fei Liu, Yuqing Feng, Li Yao, Zhiyong Hou, Xiaofeng Song, Hongchuan Zhao, Xiaoya Li, Yingdian Wang, Cheng Xiao and Baoli Zhu in Therapeutic Advances in Chronic Disease</p
- …
